UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033

2018

Volltextzugriff (PDF)

A new milestone on the road to global standardization of apolipoprotein measurements

Clinical chemistry and laboratory medicine, 2023-01, Vol.61 (1), p.1-3

Langlois, Michel R.

2023

Volltextzugriff (PDF)

Investigations on the clinical utility of apolipoprotein B measurement: A research priority

European journal of preventive cardiology, 2020-08, Vol.27 (12), p.1252-1254

Langlois, Michel R

2020

Volltextzugriff (PDF)

EFLM European Urinalysis Guideline

Clinical chemistry and laboratory medicine, 2024-08, Vol.62 (9), p.1649-1650

2024

Volltextzugriff (PDF)

The CCA Special Issue on Cardiovascular Markers

Clinica chimica acta, 2021-01, Vol.512, p.121-121

2021

Volltextzugriff (PDF)

Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study

British journal of nutrition, 2015-02, Vol.113 (4), p.665-671

2015

Volltextzugriff (PDF)

Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?

Current cardiology reports, 2020-06, Vol.22 (8), p.67-67, Article 67

2020

Volltextzugriff (PDF)

Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol

Biochemia Medica, 2022-02, Vol.32 (1), p.010704-61

2022

Volltextzugriff (PDF)

Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol

Journal of the American Heart Association, 2023-08, Vol.12 (15), p.e030405-e030405

2023

Volltextzugriff (PDF)

Why are clinical practice guidelines not followed?

Clinical chemistry and laboratory medicine, 2016-07, Vol.54 (7), p.1133-1139

2016

Volltextzugriff (PDF)

Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?

Clinical chemistry and laboratory medicine, 2009-02, Vol.47 (2), p.128-137

2009

Volltextzugriff (PDF)

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Archives of medical science, 2017-08, Vol.13 (5), p.965-1005

2017

Volltextzugriff (PDF)

How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Laboratory Medicine Task Group on Cardiac Markers

Clinical chemistry (Baltimore, Md.), 2021-08, Vol.67 (8), p.1144-1152

2021

Volltextzugriff (PDF)

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE)

Clinical chemistry (Baltimore, Md.), 2016-09, Vol.62 (9), p.1264-1271

2016

Volltextzugriff (PDF)

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Clinical chemistry and laboratory medicine, 2020-03, Vol.58 (4), p.496-517

2020

Volltextzugriff (PDF)

Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study

Clinica chimica acta, 2020-12, Vol.511, p.59-66

2020

Volltextzugriff (PDF)

Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysis patients

Clinica chimica acta, 2013-01, Vol.415, p.255-260

2013

Volltextzugriff (PDF)

Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing

Clinical chemistry and laboratory medicine, 2012-07, Vol.50 (7), p.1169-1181

Langlois, Michel R.

2012

Volltextzugriff (PDF)

Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?

Current cardiology reports, 2018-10, Vol.20 (10), p.88-88, Article 88

2018

Volltextzugriff (PDF)

Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee

Clinical chemistry and laboratory medicine, 2024-03, Vol.62 (4), p.608-614

2024

Volltextzugriff (PDF)

How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study

Clinica chimica acta, 2020-09, Vol.508, p.267-272

2020

Volltextzugriff (PDF)

Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation

Clinical chemistry and laboratory medicine, 2017-08, Vol.55 (9), p.e189

2017

Volltextzugriff (PDF)

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group

Atherosclerosis, 2014-03, Vol.233 (1), p.83-90

2014

Volltextzugriff (PDF)

1 – 25 von 619

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(508)
Mit Volltextzugriff
(522)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

A new milestone on the road to global standardization of apolipoprotein measurements

Investigations on the clinical utility of apolipoprotein B measurement: A research priority

EFLM European Urinalysis Guideline

The CCA Special Issue on Cardiovascular Markers

Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study

Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?

Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol

Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol

Why are clinical practice guidelines not followed?

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Laboratory Medicine Task Group on Cardiac Markers

Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE)

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study

Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysis patients

Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing

Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?

Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee

How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study

Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group

Suchergebnisse filtern